Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 4/2000

01-04-2000

Increased Lymphocyte Replicative Index Following 2,4–Dichlorophenoxyacetic Acid Herbicide Exposure

Authors: Larry W. Figgs, Nina Titenko Holland, Nathanial Rothman, Shelia Hoar Zahm, Robert E. Tarone, Robert Hill, Robert F. Vogt, Martyn T. Smith, Cathy D. Boysen, Frederick F. Holmes, Karen VanDyck, Aaron Blair

Published in: Cancer Causes & Control | Issue 4/2000

Login to get access
Metadata
Title
Increased Lymphocyte Replicative Index Following 2,4–Dichlorophenoxyacetic Acid Herbicide Exposure
Authors
Larry W. Figgs
Nina Titenko Holland
Nathanial Rothman
Shelia Hoar Zahm
Robert E. Tarone
Robert Hill
Robert F. Vogt
Martyn T. Smith
Cathy D. Boysen
Frederick F. Holmes
Karen VanDyck
Aaron Blair
Publication date
01-04-2000
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 4/2000
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1008925824242

Other articles of this Issue 4/2000

Cancer Causes & Control 4/2000 Go to the issue

Note

Divestment in the Tobacco Industry

OriginalPaper

Sources of Phytoestrogen Exposure among Non-Asian Women in California, USA

OriginalPaper

Allergic Disorders and the Risk of Childhood Acute Lymphoblastic Leukemia (United States)

OriginalPaper

Assessing Phytoestrogen Exposure in Epidemiologic Studies: Development of a Database (United States)

OriginalPaper

Future Trends in Breast, Cervical, Lung, Mouth and Pharyngeal Cancer Incidence in Slovenia

OriginalPaper

Influence of Vegetables on the Expression of GSTP1 in Humans — a Pilot Intervention Study (Sweden)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits